Credit Agricole S A Pfizer Inc Call Options Transaction History

Credit Agricole S A

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $33 Million - $37.9 Million	-1,275,000 Reduced 83.61%	250,000 $6.94 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $37.9 Million - $49.2 Million	1,450,000 Added 1933.33%	1,525,000 $43.9 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $2.14 Million - $2.5 Million	66,562 Added 788.84%	75,000 $2.49 Million
Q2 2023 Jul 31, 2023	BUY	$36.12 - $41.79 $304,780 - $352,624	8,438 New	8,438 $309,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $1.98 Million - $2.58 Million	47,334 New	47,334 $2.43 Million

Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $508,000 - $596,000	16,000 New	16,000 $587,000
Q2 2017 Aug 14, 2017	BUY	N/A	0	0 $0

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.